Results 31 to 40 of about 1,089,521 (397)

Platelet inhibitory effects of the Phase 3 anticancer and normal tissue cytoprotective agent, RRx-001. [PDF]

open access: yes, 2018
The platelet inhibitory effects of the Phase 3 anticancer agent and nitric oxide (NO) donor, RRx-001, (1-bromoacetyl-3,3-dinitroazetidine) were examined ex vivo and compared with the diazeniumdiolate NO donor, diethylenetriamine NONOate (DETA-NONOate ...
Bryan Oronsky   +3 more
core   +1 more source

Thrombopoietin and platelet aggregation in patients with stable coronary artery disease

open access: yesPlatelets, 2017
Thrombopoietin (TPO) may facilitate platelet activation and aggregation. However, data on the impact of TPO on platelet aggregation in patients with stable coronary artery disease (CAD) are scarce.
Sanne Bøjet Larsen   +5 more
doaj   +1 more source

Platelet aggregation and quality control of platelet concentrates produced in the Amazon Blood Bank

open access: yesRevista Brasileira de Hematologia e Hemoterapia, 2011
BACKGROUND: The study of platelet aggregation is essential to assess in vitro platelet function by different platelet activation pathways. OBJECTIVE: To assess aggregation and biochemical parameters of random platelet concentrates produced at the ...
Maria José Dantas Coêlho   +6 more
doaj   +1 more source

Genome-wide association study of platelet aggregation in African Americans

open access: yesBMC Genetics, 2015
We have previously shown that platelet aggregation has higher heritability in African Americans than European Americans. However, a genome-wide association study (GWAS) of platelet aggregation in African Americans has not been reported.
R. Qayyum   +9 more
semanticscholar   +1 more source

MMP-13 binds to platelet receptors αIIbβ3 and GPVI and impairs aggregation and thrombus formation. [PDF]

open access: yes, 2018
BACKGROUND: Acute thrombotic syndromes lead to atherosclerotic plaque rupture with subsequent thrombus formation, myocardial infarction and stroke. Following rupture, flowing blood is exposed to plaque components, including collagen, which triggers ...
Farndale, Richard W   +6 more
core   +4 more sources

Genetic determinants of on-aspirin platelet reactivity: focus on the influence of PEAR1.

open access: yesPLoS ONE, 2014
BackgroundPlatelet aggregation during aspirin treatment displays considerable inter-individual variability. A genetic etiology likely exists, but it remains unclear to what extent genetic polymorphisms determine platelet aggregation in aspirin-treated ...
Morten Würtz   +4 more
doaj   +1 more source

Platelet aggregation in healthy women during normal pregnancy - a longitudinal study

open access: yesPlatelets, 2019
Increased platelet activation is involved in obstetric complications such as preeclampsia and intrauterine growth retardation. It is of interest to study platelet aggregation during pregnancy, since increased aggregation theoretically could be a ...
Lennart Rune Fredrik Blomqvist   +3 more
doaj   +1 more source

PLATELET AGGREGATION

open access: yesThe Professional Medical Journal, 2018
The herbal use for medical purposes is increasing world over. Aloe vera is onesuch herb with established anti-inflammatory action. It has great prospect in terms of replacingtraditional NSAIDS due to better side effect profile on gastrointestinal tract but its effect onplatelet aggregation is what needs to be determined.
Sidra Mushtaq   +5 more
openaire   +4 more sources

No impact of polymorphism in the phosphodiesterase 5A gene in Cavalier King Charles Spaniels on pimobendan‐induced inhibition of platelet aggregation response

open access: yesJournal of Veterinary Internal Medicine, 2023
Background A variant in the canine phosphodiesterase (PDE) 5A gene (PDE5A:E90K) is associated with decreased concentrations of circulating cyclic guanosine monophosphate (cGMP) and response to PDE5 inhibitor treatment.
Maria J. Reimann   +9 more
doaj   +1 more source

Thrombospondin promotes platelet aggregation [PDF]

open access: yesBlood, 1988
Abstract Thrombospondin (TSP), isolated from human platelets, promotes aggregation of both nonstimulated platelets and platelets stimulated with thrombin or ADP. The TSP-promoted aggregation is specific since a monoclonal antibody against TSP inhibits the effect of exogenously added TSP and inhibits thrombin-induced platelet aggregation ...
G P, Tuszynski   +4 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy